UBASH3A and dermatomyositis: Furthermore, double immunofluorescence staining of CD4 and UBASH3A in CD4+ T cells from lymph nodes showed weaker UBASH3A staining in RA patients compared with dermatomyositis patients (Fig. 1F and Supplementary Figure 3).